Literature DB >> 34568874

"Just because I don't bleed, doesn't mean I don't go through it": Expanding knowledge on trans and non-binary menstruators.

A J Lowik1.   

Abstract

OBJECTIVES: Critical menstruation studies is a field in its nascence, marginalized within the broader area of reproductive health research. Menstruation-related research is virtually absent from trans studies, itself a marginalized field of inquiry. This article focuses on the experiences of trans and non-binary menstruators, to contribute to this burgeoning area of study.
METHODS: This article involves secondary data analysis of a qualitative dissertation research study on trans people's reproductive lives, health, and decision-making processes. Of the fourteen participants in the broader study, eleven discussed their perceptions of and experiences with menstruation and menstrual health. Those experiences where subjected to thematic narrative analysis, with a focus on themes that were substantively significant.
RESULTS: Participants describe experiences with amenorrhea associated with the use of testosterone, menstrual resumption following the cessation of testosterone and for other reasons, menstruation-related dysphoria management strategies beyond medical interventions, as well as barriers to menstruation-related health care. One participant describes bloodless periods as a trans woman, a phenomenon altogether absent from the clinical and experiential literature in this field. The article explores how cisnormativity, repronormativity and transnormativity informed the participants experiences of menstruation and reproductive health care.
CONCLUSIONS: Contributing novel stories to the literature, this article illustrates how clinically focused research fails to attend to the experiential components of menstruation for trans and non-binary people. Expanded knowledge is beneficial to the development of gender-inclusive menstruation research, clinical interventions, healthcare environments, and activist efforts.
© 2020 Taylor & Francis Group, LLC.

Entities:  

Keywords:  Transgender; menstruation; non-binary; reproductive health; secondary analysis

Year:  2021        PMID: 34568874      PMCID: PMC8040688          DOI: 10.1080/15532739.2020.1819507

Source DB:  PubMed          Journal:  Int J Transgend Health        ISSN: 2689-5269


  16 in total

Review 1.  The language of 'experience' in nursing research.

Authors:  David Allen; Kristin Cloyes
Journal:  Nurs Inq       Date:  2005-06       Impact factor: 2.393

2.  Time for OBGYNs to care for people of all genders.

Authors:  Juno Obedin-Maliver
Journal:  J Womens Health (Larchmt)       Date:  2015-02       Impact factor: 2.681

3.  Experiences of Gender Minority Youth With the Intrauterine System.

Authors:  Sinem Akgul; Andrea E Bonny; Nancy Ford; Cynthia Holland-Hall; Gayathri Chelvakumar
Journal:  J Adolesc Health       Date:  2019-01-26       Impact factor: 5.012

4.  Welcoming transgender and nonbinary patients: expanding the language of "women's health".

Authors:  Daphna Stroumsa; Justine P Wu
Journal:  Am J Obstet Gynecol       Date:  2018-09-26       Impact factor: 8.661

5.  Approaches to Vaginal Bleeding and Contraceptive Counseling in Transgender and Gender Nonbinary Patients.

Authors:  Amanda R Schwartz; Kristen Russell; Beverly A Gray
Journal:  Obstet Gynecol       Date:  2019-07       Impact factor: 7.661

Review 6.  Contraception across the transmasculine spectrum.

Authors:  Chance Krempasky; Miles Harris; Lauren Abern; Frances Grimstad
Journal:  Am J Obstet Gynecol       Date:  2019-08-05       Impact factor: 8.661

Review 7.  Contraception Care for Transmasculine Individuals on Testosterone Therapy.

Authors:  Danielle Boudreau; Ronica Mukerjee
Journal:  J Midwifery Womens Health       Date:  2019-04-18       Impact factor: 2.388

8.  "I don't think this is theoretical; this is our lives": how erasure impacts health care for transgender people.

Authors:  Greta R Bauer; Rebecca Hammond; Robb Travers; Matthias Kaay; Karin M Hohenadel; Michelle Boyce
Journal:  J Assoc Nurses AIDS Care       Date:  2009 Sep-Oct       Impact factor: 1.354

9.  Dose-response analysis of testosterone replacement therapy in patients with female to male gender identity disorder.

Authors:  Aya Nakamura; Masami Watanabe; Morito Sugimoto; Tomoko Sako; Sabina Mahmood; Haruki Kaku; Yasutomo Nasu; Kazushi Ishii; Atsushi Nagai; Hiromi Kumon
Journal:  Endocr J       Date:  2012-10-27       Impact factor: 2.349

10.  The Response of the Menstrual Cycle to Initiation of Hormonal Therapy in Transgender Men.

Authors:  Shazia Ahmad; Matthew Leinung
Journal:  Transgend Health       Date:  2017-10-01
View more
  4 in total

Review 1.  The messiness of the menstruator: assessing personas and functionalities of menstrual tracking apps.

Authors:  Adrienne Pichon; Kasey B Jackman; Inga T Winkler; Chris Bobel; Noémie Elhadad
Journal:  J Am Med Inform Assoc       Date:  2022-01-12       Impact factor: 4.497

2.  Experiences of menstrual inequity and menstrual health among women and people who menstruate in the Barcelona area (Spain): a qualitative study.

Authors:  Anna Sofie Holst; Constanza Jacques-Aviñó; Anna Berenguera; Diana Pinzón-Sanabria; Carme Valls-Llobet; Jordina Munrós-Feliu; Cristina Martínez-Bueno; Tomàs López-Jiménez; Mª Mercedes Vicente-Hernández; Laura Medina-Perucha
Journal:  Reprod Health       Date:  2022-02-19       Impact factor: 3.223

3.  Use and perceptions on reusable and non-reusable menstrual products in Spain: A mixed-methods study.

Authors:  Laura Medina-Perucha; Tomàs López-Jiménez; Anna Sofie Holst; Constanza Jacques-Aviñó; Jordina Munrós-Feliu; Cristina Martínez-Bueno; Carme Valls-Llobet; Diana Pinzón Sanabria; Mª Mercedes Vicente-Hernández; Anna Berenguera
Journal:  PLoS One       Date:  2022-03-17       Impact factor: 3.240

4.  Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination.

Authors:  Katharine M N Lee; Eleanor J Junkins; Chongliang Luo; Urooba A Fatima; Maria L Cox; Kathryn B H Clancy
Journal:  Sci Adv       Date:  2022-07-15       Impact factor: 14.957

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.